Anthropic reported that it has achieved initial success in drug development using Claude. The company has entered into agreements with several laboratories and biotechnology firms that use Claude in research related to the treatment of cancer and allergies, as well as for process optimization.Among Anthropic's partners are BigHat Biosciences, Bristol Myers Squibb, Divergence Labs, Enveda, Generate Biomedicines, and The Column Group. In addition, the compan